Boronic Prodrug of Endoxifen as an Effective Hormone Therapy for Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-015-3461-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

Pharmacogenetics in Breast Cancer Hormone Therapy

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2010English

Hormone Therapy in Mastitis and Breast Cancer

BMJ
1938English

Bisphosphonates as Adjuvant Therapy for Breast Cancer

Women's Health
Medicine
2006English

Image-Guided Enzyme/Prodrug Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

Menopausal Hormone Therapy and 20-Year Breast Cancer Mortality

The Lancet
Medicine
2019English

Palbociclib in Combination With Hormone Therapy for Luminal Her2-Negative Metastatic Breast Cancer: New Highly Effective Strategy of Drug Treatment

Tumors of female reproductive system
2017English

Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy